Current development strategies have expanded beyond conventional synthetic small-molecule inhibitors to encompass natural product screening, reflecting an increasing trend toward diversification.
← all excerpts
Long-chain acyl-CoA synthetases: biological functions, diseases and therapeutic targets.
1
—
—